| [1] |
郑荣寿，孙可欣，张思维，等．2015年中国恶性肿瘤流行情况分析[J]．中华肿瘤杂志，2019, 41(1):19-28.
|
| [2] |
Cremolini C, Loupakis F, Antoniotti C, et al. FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study[J]. Lancet Oncol, 2015, 16(13):1306-1315.
|
| [3] |
Adam R, Kitano Y. Multidisciplinary approach of liver metastases from colorectal cancer[J]. Ann Gastroenterol Surg, 2019, 3(1):50-56.
|
| [4] |
Ekberg H, Tranberg KG, Andersson R, et al. Determinants of survival in liver resection for colorectal secondaries[J]. Br J Surg, 1986, 73(9):727-731.
|
| [5] |
Adam R. Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases[J]. Ann Oncol, 2003, 14 Suppl 2: ii13-16.
|
| [6] |
de Haas RJ, Wicherts DA, Andreani P, et al. Impact of expanding criteria for resectability of colorectal metastases on short- and long-term outcomes after hepatic resection[J]. Ann Surg, 2011, 253(6): 1069-1079.
|
| [7] |
Chakedis J, Squires MH, Beal EW, et al. Update on current problems in colorectal liver metastasis[J]. Curr Probl Surg, 2017, 54(11):554-602.
|
| [8] |
Pawlik TM, Scoggins CR, Zorzi D, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases[J]. Ann Surg, 2005, 241(5):715-722.
|
| [9] |
Hamady ZZ, Lodge JP, Welsh FK, et al. One-millimeter cancer-free margin is curative for colorectal liver metastases: a propensity score case-match approach[J]. Ann Surg, 2014, 259(3):543-548.
|
| [10] |
Margonis GA, Sergentanis TN, Ntanasis-Stathopoulos I, et al. Impact of surgical margin width on recurrence and overall survival following R0 hepatic resection of colorectal metastases: a systematic review and meta-analysis[J]. Ann Surg, 2018, 267(6):1047-1055.
|
| [11] |
Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival[J]. Ann Surg, 2004, 240(4):644-657.
|
| [12] |
Folprecht G, Gruenberger T, Bechstein W, et al. Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study)[J]. Ann Oncol, 2014, 25(5):1018-1025.
|
| [13] |
魏哲威，何裕隆，余捷，等．结直肠癌肝转移术后mFOLFOX6方案与XELOX方案辅助化疗的疗效观察[J/CD]．消化肿瘤杂志（电子版），2018, 10(3):153-156.
|
| [14] |
Imai K, Allard MA, Benitez CC, et al. Early recurrence after hepatectomy for colorectal liver metastases: what optimal definition and what predictive factors?[J]. Oncologist, 2016, 21(7):887-894.
|
| [15] |
Dupré A, Jones RP, Diaz-Nieto R, et al. Curative-intent treatment of recurrent colorectal liver metastases: a comparison between ablation and resection[J]. Eur J Surg Oncol, 2017, 43(10):1901-1907.
|
| [16] |
Wang SJ, Si XY, Cai ZB, et al. Survival after repeat hepatectomy for recurrent colorectal liver metastasis: a review and meta-analysis of prognostic factors[J]. Hepatobiliary Pancreat Dis Int, 2019, 18(4): 313-320.
|
| [17] |
刘铭，王崑，包全，等．保留肝实质的治疗方式在结直肠癌肝转移手术切除中的应用分析[J]．中国肿瘤临床，2017, 44(23):1179-1183.
|
| [18] |
Schadde E, Ardiles V, Robles-Campos R, et al. Early survival and safety of ALPPS: first report of the International ALPPS Registry[J]. Ann Surg, 2014, 260(5):829-836.
|
| [19] |
Viganò L, Procopio F, Cimino MM, et al. Is tumor detachment from vascular structures equivalent to R0 resection in surgery for colorectal liver metastases? an observational cohort[J]. Ann Surg Oncol, 2016, 23(4):1352-1360.
|
| [20] |
Allard MA, Cunha AS, Gayet B, et al. Early and long-term oncological outcomes after laparoscopic resection for colorectal liver metastases:a propensity score-based analysis[J]. Ann Surg, 2015, 262(5):794-802.
|
| [21] |
Grut H, Dueland S, Line PD, et al. The prognostic value of F-FDG PET/CT prior to liver transplantation for nonresectable colorectal liver metastases[J]. Eur J Nucl Med Mol Imaging, 2018, 45(2):218-225.
|
| [22] |
Toso C, Pinto Marques H, Andres A, et al. Liver transplantation for colorectal liver metastasis: Survival without recurrence can be achieved[J]. Liver Transpl, 2017, 23(8):1073-1076.
|
| [23] |
袁航，滕飞，丁国善．转移性肝癌肝移植的临床研究进展[J/CD]. 实用器官移植电子杂志，2019, 7(1):31-34.
|
| [24] |
Kelly ME, Spolverato G, Lê GN, et al. Synchronous colorectal liver metastasis: a network meta-analysis review comparing classical, combined, and liver-first surgical strategies[J]. J Surg Oncol, 2015, 111(3):341-351.
|
| [25] |
Benoist S, Brouquet A, Penna C, et al. Complete response of colorectal liver metastases after chemotherapy: does it mean cure?[J]. J Clin Oncol, 2006, 24(24):3939-3945.
|
| [26] |
Ono T, Ishida H, Kumamoto K, et al. Outcome in disappearing colorectal cancer liver metastases during oxaliplatin-based chemotherapy[J]. Oncol Lett, 2012, 4(5):905-909.
|